drugset / Trial / NCT06513208
Ketorolac Effects on Post-operative Pain and Lumbar Fusion
Phase 4
Recruiting
140 enrolled
University of Maryland St. Joseph Medical Center
Medical Metrics Diagnostics, Inc · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Timeline
- Start
- 2026-01
- Primary completion
- 2027-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 15 mg | Intravenous |
Indications
No indication recorded.